Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. - Wikidata - awgldk - TriplyDB

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.

http://www.wikidata.org/entity/Q36625957

about

Renal tumours: long-term outcome Cancer survivors in the United States: a review of the literature and a call to action Impact of late radiation effects on cancer survivor children: an integrative review Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials Late effects of treatment for wilms tumor Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial.Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.Review of cardiotoxicity in pediatric cancer patients: during and after therapy.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells.Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours.Anthracycline cardiotoxicity.Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study Anthracycline cardiotoxicity in childhood.Tissue Doppler Imaging and Focal, Late-Onset Anthracycline-Induced Cardiovascular Disease in Long Term Survivors of Childhood Cancer: A Research Article Review: doxorubicin delivery systems based on chitosan for cancer therapy.Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up.Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Current views on anthracycline cardiotoxicity.Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.Plasma natriuretic peptides levels and echocardiographic findings in late subclinical anthracycline toxicity.Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.Cardiac response to doxorubicin and dexrazoxane in intact and ovariectomized young female rats at rest and after swim training.The effect of oxidized low-density lipoprotein (ox-LDL) on radiation-induced endothelial-to-mesenchymal transition.Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts

P2860

Q26828577-8A4C85BD-6DAD-4FAA-86ED-C8A84E676CB4 Q26865247-02EF98C8-B9C8-48C9-AA0C-18249F0B9EE3 Q28085523-9691E856-60F5-42F0-81C2-FC113FAD178F Q33423926-D7E2C3DF-A29F-477F-99F2-13C2EBDBBC11 Q33619867-67E19BC3-7A38-4A24-B2E8-39F1D948E655 Q33691101-CB861DE4-9F07-48F2-AA0A-09C7ED687C6D Q33815037-6D775B75-F20E-495E-87D2-50D307607558 Q34611645-31DDFC3B-DFD9-4B93-8AC7-54A985D93A82 Q34717844-AA29CFAA-6394-436C-8C0D-14C86F454B04 Q35008126-EA39E095-B528-4F32-A6BF-226CBD901D80 Q35076156-52EAB05B-3F10-47E3-A29E-3941A9C953F8 Q35699184-D21034A7-30A6-4FD2-ADF3-6BF84188A279 Q35757419-9449C5AC-3BE8-4753-9CDB-9EA5D79E0F61 Q35797623-74CC4CCE-13C8-491C-ABBE-A3235BE443E9 Q35903199-489A2F71-CC53-404C-B9CF-10F16BE1ADFF Q36030052-CFB81AB1-2F21-4D99-8ED3-4C9038FD3F22 Q36049496-550878B4-55DD-48A0-A2AE-75AAB9986EF6 Q36416745-A9B9F9F0-1308-476C-A8DD-0DB7A99A870A Q36451899-C9147DDD-3D21-4ECC-8487-5C4120D7BA37 Q36612320-E61E116C-BF5F-4E73-84F5-5594D08056EC Q36624983-8CD5BDD2-88E4-42FD-8006-E43A2BBA698A Q36732654-DD265979-BB32-4109-821D-05EE57EE2AB7 Q37165394-D2288B18-EF4C-4BE7-A132-AB58D498CB6A Q37266712-25B34860-B103-425D-817B-4A409C638ADE Q37380142-5912AF31-C461-412D-B3B7-A0C617575052 Q37729947-2F2A7B1E-83A6-49EC-BFF9-1C8E42179782 Q37783289-3855281A-1AFF-4276-852A-8D4EF02BC152 Q38021523-2B65539A-C83C-4A48-8165-80FF55E6DCC3 Q38079197-44BA119D-0CE5-4543-80DE-9D18F40F6513 Q38205702-9817F25B-5814-401A-A61B-9689CF5A0FD8 Q38845535-0C9FBCA0-78BC-4BB6-971D-BCDD1609234F Q39012650-3FBFF2B8-2B23-43E5-A849-2BFF66A38C11 Q48809762-D9C342B3-9233-4505-855B-43A14F397330 Q51277742-8A853214-33F7-4B02-A2B6-3DF48BC293BF Q51294069-0A4AE9A3-EB18-47AB-9396-667491F3C6B6 Q51350978-FBD09D05-9CBE-4685-BE07-00CA50248404 Q53126395-B002DFFC-6CBC-41C8-A6BB-B8F65B9098A0 Q58696664-1626B8B8-73A6-444E-B67B-5B77B74EC854 Q58708873-10209638-44DD-4E0E-89F5-490414BB226C

P2860

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.

http://www.wikidata.org/entity/Q36625957

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@ast

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@en

type

label

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@ast

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@en

prefLabel

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@ast

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@en

P1433

Q36625957-2A3DC72D-4CB6-41BD-93C0-27E61F3B5690

P1476

Q36625957-D4BF0AEA-D835-49DB-B827-09D65630ABFF

P2093

Q36625957-125AA342-1867-460C-9E20-FAFD46DB3C0C

Q36625957-45CD886A-8072-429E-B311-8AE63940A1CC

Q36625957-4F82EADD-AEA5-4BA2-AF67-878613BEA493

Q36625957-6B49B0C0-3667-44D6-90A1-A5E653A4B031

Q36625957-6C7DB19E-2EB1-4C3C-98F4-D45C52CD6035

Q36625957-6F687702-107D-4BE0-BB4A-28A0A73F93D7

Q36625957-B758E6F3-C353-481D-AAAA-D8CA81577816

Q36625957-C48D09B3-5C7A-4381-92FC-1ACEDD5F0265

Q36625957-D34EB99B-2501-4858-A923-89DFDA52B3FE

Q36625957-FD0457CE-A477-4E59-AB57-25D41E54DBC1

P2860

Q36625957-0049FC68-4B45-4FCB-AA30-72B9F6DD3A82

Q36625957-05B5A8D3-95AA-4E69-973E-921EFBE2A7F0

Q36625957-06E005B6-F928-4C19-BBB2-70A64DB9EA3D

Q36625957-07AF6EFA-58C8-4DDB-B108-65FC027A63F4

Q36625957-07E2B91F-A827-49BB-ABF6-613C2C3F02BA

Q36625957-18C545B7-301C-4544-BD36-2C9A1E33AD38

Q36625957-364C3A68-04BE-4752-9CBB-17CC65829CBA

Q36625957-49DA4D9F-6F60-4F03-B12D-141BF9250C21

Q36625957-51DBE59D-D748-41C1-B4A7-7C7A19D0010E

Q36625957-5714EB7C-2424-4E54-9AD0-F5A1216EA38D

P2888

Q36625957-B344D169-F049-45F5-ADB8-DD4C7ACB4A16

P304

Q36625957-0D6C3A6B-2DBA-4C35-8C6F-D1FC1B96DB59

P31

Q36625957-388E2978-91D8-4E5F-B5AE-9FE6F84463F3

P356

Q36625957-34EECB86-DEFD-4787-BC3A-8C3F6995E9D2

P407

Q36625957-16A8E453-E356-4980-8F5B-A0BC189693C3

P433

Q36625957-F8EB56B5-1337-46B4-9C51-239C4F8628F3

P478

Q36625957-1C00F0A5-458B-42FB-9BB1-0D0E9D24EF57

P577

Q36625957-08C01A35-7563-4FB4-9CD1-A0280DCA8755

P5875

Q36625957-948F9520-BB8F-485A-AE98-ED0E51E182BB

P698

Q36625957-909BA5B5-9F13-4B70-BEA8-EE63933FB44F

P932

Q36625957-6CC8D5C6-E6F4-410B-8617-FF881B6EC4C0

P356

P1433

British Journal of Cancer

P1476

Cardiac abnormalities 15 years ...... t the Institut Gustave Roussy.

@en

P2093

A Shamsaldin

http://www.w3.org/2001/XMLSchema#string

D Sidi

http://www.w3.org/2001/XMLSchema#string

E Villain

http://www.w3.org/2001/XMLSchema#string

F Pein

http://www.w3.org/2001/XMLSchema#string

F de Vathaire

http://www.w3.org/2001/XMLSchema#string

J Lebidois

http://www.w3.org/2001/XMLSchema#string

M Dahan

http://www.w3.org/2001/XMLSchema#string

O Hartmann

http://www.w3.org/2001/XMLSchema#string

O Sakiroglu

http://www.w3.org/2001/XMLSchema#string

P Merlet

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for doxorubicin-induced congestive heart failure

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients.

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

Epidemiology of anthracycline cardiotoxicity in children and adults.

Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

P2888

P304

37-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601904

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8544597

http://www.w3.org/2001/XMLSchema#string

P698

15162142

http://www.w3.org/2001/XMLSchema#string

P932

2364747

http://www.w3.org/2001/XMLSchema#string